Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

Clinical trial NCT04634916 · RECRUITING

Trial details

NCT number: NCT04634916
Sponsor: C. R. Bard
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Kidney Disease, End-Stage End-stage Renal Disease Arteriovenous Fistula

Start date: 2021-03-26
Primary completion: 2027-06-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.